150 related articles for article (PubMed ID: 15078189)
1. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease.
Zhang X
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):137-52. PubMed ID: 15078189
[TBL] [Abstract][Full Text] [Related]
2. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.
Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
Prog Neurobiol; 1998 Dec; 56(5):541-69. PubMed ID: 9775403
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.
Ahmed T; Zahid S; Mahboob A; Farhat SM
Curr Neuropharmacol; 2017; 15(4):480-494. PubMed ID: 27012953
[TBL] [Abstract][Full Text] [Related]
7. Alterations of functional circuitry in aging brain and the impact of mutated APP expression.
Bearer EL; Manifold-Wheeler BC; Medina CS; Gonzales AG; Chaves FL; Jacobs RE
Neurobiol Aging; 2018 Oct; 70():276-290. PubMed ID: 30055413
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh.
Isacson O; Seo H; Lin L; Albeck D; Granholm AC
Trends Neurosci; 2002 Feb; 25(2):79-84. PubMed ID: 11814559
[TBL] [Abstract][Full Text] [Related]
9. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
10. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
11. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
[TBL] [Abstract][Full Text] [Related]
12. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
[TBL] [Abstract][Full Text] [Related]
13. Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.
Schliebs R
Neurochem Res; 2005; 30(6-7):895-908. PubMed ID: 16187224
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic activity and amyloid precursor protein metabolism.
Roberson MR; Harrell LE
Brain Res Brain Res Rev; 1997 Sep; 25(1):50-69. PubMed ID: 9370050
[TBL] [Abstract][Full Text] [Related]
15. Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice.
Liu L; Ikonen S; Tapiola T; Tanila H; van Groen T
Exp Neurol; 2002 Oct; 177(2):565-74. PubMed ID: 12429202
[TBL] [Abstract][Full Text] [Related]
16. Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease.
Rimal S; Li Y; Vartak R; Geng J; Tantray I; Li S; Huh S; Vogel H; Glabe C; Grinberg LT; Spina S; Seeley WW; Guo S; Lu B
Acta Neuropathol Commun; 2021 Oct; 9(1):169. PubMed ID: 34663454
[TBL] [Abstract][Full Text] [Related]
17. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
[TBL] [Abstract][Full Text] [Related]
18. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
[TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease.
Ling Y; Morgan K; Kalsheker N
Int J Biochem Cell Biol; 2003 Nov; 35(11):1505-35. PubMed ID: 12824062
[TBL] [Abstract][Full Text] [Related]
20. Role of amyloid beta in lipid homeostasis.
Grösgen S; Grimm MO; Friess P; Hartmann T
Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
